![Mahesh Nathalal Shah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mahesh Nathalal Shah
Keine laufenden Positionen mehr
Karriereverlauf von Mahesh Nathalal Shah
Ehemalige bekannte Positionen von Mahesh Nathalal Shah
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Direktor/Vorstandsmitglied | 11.12.1999 | - |
Technik-/Wissenschafts-/F&E-Leiter | 11.12.1999 | - |
Ausbildung von Mahesh Nathalal Shah
University of Mumbai | Undergraduate Degree |
Gujarat University | Graduate Degree |
Statistik
International
Indien | 4 |
Operativ
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Börse
- Insiders
- Mahesh Nathalal Shah
- Erfahrung